...
首页> 外文期刊>Cardiovascular and Interventional Radiology: A Journal of Imaging in Diagnosis and Treatment >Safety and Efficacy of Totally Percutaneous Femoral Access for Fenestrated-Branched Endovascular Aortic Repair of Pararenal-Thoracoabdominal Aortic Aneurysms
【24h】

Safety and Efficacy of Totally Percutaneous Femoral Access for Fenestrated-Branched Endovascular Aortic Repair of Pararenal-Thoracoabdominal Aortic Aneurysms

机译:完全经皮股骨进入的安全性和疗效分支血管内主动脉瘤的血管分支血管内主动脉瘤

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Introduction We sought to evaluate the safety and efficacy of totally percutaneous femoral access (TPFA) for fenestrated-branched endovascular aortic repair (F/B-EVAR) of pararenal-thoracoabdominal aortic aneurysms (PRAs/TAAAs). Methods We reviewed all consecutive patients enrolled in single-center prospective non-randomized single-arm study to investigate F/B-EVAR for PRAs/TAAAs (2013-2017). Percutaneous approach was selected in all patients when anatomically feasible; otherwise, surgical femoral access (SFA), with or without construction of temporary prosthetic conduit, was selected. Primary outcomes were technical success, mortality, major adverse events (MAEs) and major vascular access complications. Results A total of 231 patients were included in the study: TPFA was possible in 163 (70%) with technical success rate of 93%, while 68 (30%) required SFA. Patients with TPFA and SFA had similar mortality rate of 1%. The rate of MAEs for TPFA was 20% versus 38% for SFA (p = .07). The trend was mainly driven by reduced rates of estimated blood loss (EBL) >= 1L (6% vs 21%, p = .001) and acute myocardial infarction (2% vs 9%, p = .03). Similarly, TPFA carried a significantly lower rate of major vascular access complications as compared with SFA (6% vs 21%, p < .001; adjusted OR 3.4, 95% CI 1.3-8.9, p = .01). Conclusion A percutaneous-first approach for elective F/B-EVAR of PRAs/TAAAs is safe, feasible and effective when proper patient selection is provided. When the presence of hostile iliofemoral anatomy requires open-vessel exposure, higher rates of perioperative major bleeding, cardiac events and access complications may be expected.
机译:简介我们试图评估普通的分枝血管系(TPFA)对伞生素 - 胸腔腹主动脉瘤(PRAS / TAAAS)的肝细胞分支血管内主动脉修复(F / B-EVAR)的安全性和有效性。方法审查了招收单中心前瞻性非随机单臂研究的所有连续患者,以调查PRAS / TAAAS(2013-2017)的F / B EVAR。在解剖学上可行的所有患者中选择经皮方法;否则,选择了手术股票(SFA),有或没有临时假肢导管的施工。主要结果是技术成功,死亡率,主要不良事件(MAES)和主要的血管接入并发症。结果共有231名患者纳入研究:TPFA可以在163(70%)中,技术成功率为93%,而68(30%)所需的SFA。 TPFA和SFA患者具有相似的死亡率为1%。 SFA的TPFA的MAE的速率为20%,而38%(p = .07)。该趋势主要由估计血液损失(EBL)> = 1L的速率降低(6%vs 21%,p = .001)和急性心肌梗死(2%vs 9%,p = .03)。同样,与SFA相比,TPFA培养了主要的血管存取并发症的显着较低速率(6%vs 21%,P <.001;调整后的或3.4,95%CI 1.3-8.9,P = .01)。结论PRAS / TAAAS的选修F / B-EVAR的经皮第一种方法是安全的,可行的,在提供适当的患者选择时有效。当存在敌对的IlioFoMoral解剖学需要开放血管暴露时,可以预期围手术期主要出血,心脏事件和访问并发症的较高速率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号